Determination of the novel non-peptidic HIV-protease inhibitor tipranavir by HPLC-UV after solid-phase extraction

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 832, Issue 1, 2006, Pages 138-143

  Colombo, S ^a   Beguin A ^a   Marzolini, C ^a,b   Telenti, A ^a   Biollaz, J ^a   Decosterd, L A ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ion pair HPLC; Protease inhibitors; Solid phase extraction; Therapeutic drug monitoring; Tipranavir

Indexed keywords

EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHOSPHATES;

ION PAIR HPLC; PROTEASE INHIBITORS; SOLID PHASE EXTRACTION; THERAPUTEIC DRUG MONITORING; TRIPRANAVIR;

ENZYMES;

ABACAVIR; ACENOCOUMAROL; ACETYLSALICYLIC ACID; AMLODIPINE BESYLATE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPRENAVIR; AMPRENAVIR PHOSPHATE; ATAZANAVIR; ATENOLOL PLUS CHLORTALIDONE; ATORVASTATIN; AZATHIOPRINE; AZITHROMYCIN; BROMAZEPAM; CANDESARTAN HEXETIL; CEFEPIME; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CISAPRIDE; COTRIMOXAZOLE; CYCLOSPORIN A; DIAZEPAM; DIDANOSINE; EFAVIRENZ; ESOMEPRAZOLE; FLUCONAZOLE; INDINAVIR; ITRACONAZOLE; KREON; LAMIVUDINE PLUS ZIDOVUDINE; LEVOFLOXACIN; LOPERAMIDE; LOPINAVIR PLUS RITONAVIR; MEFENAMIC ACID; MEROPENEM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NELFINAVIR; NEVIRAPINE; OXAZEPAM; PHOSPHATE BUFFERED SALINE; PREDNISONE; RIFAMPICIN; RISEDRONIC ACID; RITONAVIR; SALAZOSULFAPYRIDINE; SAQUINAVIR; STAVUDINE; SULFONIC ACID DERIVATIVE; TACROLIMUS; TAZOBACTAM; TENOFOVIR DISOPROXIL; TIPRANAVIR; TORASEMIDE; TRAMADOL; UNINDEXED DRUG; VANCOMYCIN; VORICONAZOLE;

ACCURACY; ARTICLE; CALIBRATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG BLOOD LEVEL; EVAPORATION; HEAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PH; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; ULTRAVIOLET RADIATION; VALIDATION STUDY; VIRUS INACTIVATION;

CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HIV PROTEASE INHIBITORS; HUMANS; PYRIDINES; PYRONES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

PEPPER GOLDEN MOSAIC VIRUS - [MEXICO];

EID: 32244433196     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2005.11.040     Document Type: Article

References (26)

1. S. Rusconi, C.S. La Seta, P. Citterio, S. Kurtagic, M. Violin, C. Balotta, M. Moroni, M. Galli, and A. rminio-Monforte Antimicrob. Agents Chemother. 44 2000 1328
2. S. Mccallister, D. Neubacher, W. Verbiest, and D. Mayers Antiv. Ther. 2002 S106 Abstract 127
3. V.R. Kandula, H. Khanlou, and C. Farthing Expert Rev. Anti Infect Ther. 3 2005 9
4. Food and Drug Administration, Tipranavir, label information (NDA 21-814), 2005.
5. C. Marzolini, A. Telenti, T. Buclin, J. Biollaz, and L.A. Decosterd J. Chromatogr. B (Biomed. Sci. Appl.) 740 2000 43
6. C. Marzolini, A. Beguin, A. Telenti, A. Schreyer, T. Buclin, J. Biollaz, and L.A. Decosterd J. Chromatogr. B (Biomed. Sci. Appl.) 774 2002 127
7. N.L. Rezk, R.R. Tidwell, and A.D. Kashuba J. Chromatogr. B (Biomed. Sci. Appl.) 805 2004 241
8. E. Dailly, L. Thomas, M.F. Kergueris, P. Jolliet, and M. Bourin J. Chromatogr. B (Biomed. Sci. Appl.) 758 2001 129
9. G. Aymard, M. Legrand, N. Trichereau, and B. Diquet J. Chromatogr. B (Biomed. Sci. Appl.) 744 2000 227
10. M. Sarasa-Nacenta, Y. Lopez-Pua, J. Mallolas, J.L. Blanco, J.M. Gatell, and X. Carne J. Chromatogr. B (Biomed. Sci. Appl.) 757 2001 325
11. H. Yamada, H. Kotaki, T. Nakamura, and A. Iwamoto J. Chromatogr. B (Biomed. Sci. Appl.) 755 2001 85
12. U.S. Justesen, C. Pedersen, and N.A. Klitgaard J. Chromatogr. B (Biomed. Sci. Appl.) 783 2003 491
13. E. Dailly, F. Raffi, and P. Jolliet J. Chromatogr. B (Biomed. Sci. Appl.) 813 2004 353
14. K.M. Crommentuyn, H. Rosing, M.J. Hillebrand, A.D. Huitema, and J.H. Beijnen J. Chromatogr. B (Biomed. Sci. Appl.) 804 2004 359
15. E. Giraud, E. Rey, J.M. Treluyer, G. Pons, and V. Jullien J. Chromatogr. B (Biomed. Sci. Appl.) 830 2006 86 90
16. S. Colombo, N. Guignard, C. Marzolini, A. Telenti, J. Biollaz, and L.A. Decosterd J. Chromatogr. B (Biomed. Sci. Appl.) 810 2004 25
17. Investigator's brochure Tipranavir, Boehringer Ingelhiem, 2005.
18. V.P. Shah, K.K. Midha, S. Dighe, I.J. McGilveray, J.P. Skelly, A. Yacobi, T. Layloff, C.T. Viswanathan, C.E. Cook, R.D. McDowall, K.A. Pittman, and S. Spector Eur. J. Drug Metabol. Pharm. 16 1991 249
19. J.S. McDougal, L.S. Martin, S.P. Cort, M. Mozen, C.M. Heldebrant, and B.L. Evatt J. Clin. Invest. 76 1985 875
20. S.S. Good, D.J. Reynolds, and P. de Miranda J. Chromatogr. 431 1988 123
21. G.V. Quinnan Jr., M.A. Wells, A.E. Wittek, M.A. Phelan, R.E. Mayner, S. Feinstone, R.H. Purcell, and J.S. Epstein Transfusion 26 1986 481
22. C.H. Koks, H. Rosing, P.L. Meenhorst, A. Bult, and J.H. Beijnen J. Chromatogr. B (Biomed. Sci. Appl.) 663 1995 345
23. FDA, Home Page. Guidance for industry. http://fda.gov/cder/guidance/ index.htm, (2001).
24. V.P. Shah, K.K. Midha, J.W. Findlay, H.M. Hill, J.D. Hulse, I.J. McGilveray, G. McKay, K.J. Miller, R.N. Patnaik, M.L. Powell, A. Tonelli, C.T. Viswanathan, and A. Yacobi Pharm. Res. 17 2000 1551
25. FDA, R. Klein, K. Struble, FDA Approval of Aptivus (tipranavir), 2005.
26. Tipranavir Review Team (HFD-530), 2005. Available at: http://www.fda.gov/ohrms/dockets/ac/05/briefing/2005-4139b1-01-fda.pdf.